04th January 2022 | Pharma Updates
Why There Is a Need for Aatmanirbhar Booster Strategy
India vaccine’s manufacturing supply chain is still vulnerable to disruptions due to logistics and tariffs.
Natco Pharma buys Dash Pharma
The cost of acquisition is USD 18 MN.
More than 12.7 lakh kids Vaccinated
Only Bharat Biotech’s Covaxin has been allowed to vaccinate kids.
India Changing IP Regulations
Even without the Intellectual Property Waiver from the World Trade Organization, India is putting forward a challenge to the West’s vaccine monopoly.
Drugs Prices Upshoot, Prayagraj Traders Worry
Allahabad Drug and Chemist Association is concerned with the rising prices of life-saving drugs.
Mankind Pharma to Launch Molnupiravir at Rs 35/capsule
Mankind Pharma Chairman RC Juneja said full treatment will cost Rs 1400.
75% Covid Cases In Urban Areas Are Omicron Variant
A sheer number of Omicron cases in Delhi, Mumbai and Kolkata. They contribute to around 75%.